Roivant Sciences (ROIV) Gains from Sales and Divestitures (2022 - 2025)

Historic Gains from Sales and Divestitures for Roivant Sciences (ROIV) over the last 4 years, with Q2 2025 value amounting to $297795.0.

  • Roivant Sciences' Gains from Sales and Divestitures fell 8661.85% to $297795.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $297795.0, marking a year-over-year decrease of 8661.85%. This contributed to the annual value of $6.1 million for FY2025, which is 1102.56% down from last year.
  • As of Q2 2025, Roivant Sciences' Gains from Sales and Divestitures stood at $297795.0, which was down 8661.85% from $6.1 million recorded in Q1 2025.
  • In the past 5 years, Roivant Sciences' Gains from Sales and Divestitures registered a high of $12.0 million during Q1 2023, and its lowest value of $297795.0 during Q2 2025.
  • Moreover, its 4-year median value for Gains from Sales and Divestitures was $4.5 million (2023), whereas its average is $4.8 million.
  • In the last 5 years, Roivant Sciences' Gains from Sales and Divestitures surged by 368.1% in 2023 and then tumbled by 8661.85% in 2025.
  • Over the past 4 years, Roivant Sciences' Gains from Sales and Divestitures (Quarter) stood at $5.8 million in 2022, then dropped by 4.56% to $5.5 million in 2023, then fell by 10.21% to $4.9 million in 2024, then crashed by 93.97% to $297795.0 in 2025.
  • Its last three reported values are $297795.0 in Q2 2025, $6.1 million for Q1 2025, and $4.9 million during Q4 2024.